Keyphrases
Growth Hormone Receptor
100%
Receptor 1
100%
MRNA Expression
100%
Prognostic Marker
100%
Insulin-like
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
A1 Receptor
87%
Growth Factors
87%
Protein Expression
25%
Tissue Sampling
25%
Chemotherapy
12%
Patient with Tumor
12%
Quantitative PCR
12%
Personalized Chemotherapy
12%
Large Population
12%
Receptor Status
12%
Progression-free Survival
12%
Prognostic Biomarker
12%
Immunohistochemistry
12%
Quantitative Real-time
12%
Overall Survival
12%
Clinical Endpoints
12%
Surgical Tissues
12%
Receptor-interacting Protein Kinase 1 (RIPK1)
12%
Non-small Cell Lung Cancer (NSCLC)
12%
Prognostic Value
12%
Medicine and Dentistry
Somatomedin C Receptor
100%
Non Small Cell Lung Cancer
100%
Messenger RNA
100%
Biological Marker
25%
Protein Expression
25%
Neoplasm
12%
Receptor Protein
12%
Overall Survival
12%
Progression Free Survival
12%
Immunohistochemistry
12%
Reverse Transcription Polymerase Chain Reaction
12%
Histopathology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Somatomedin C Receptor
100%
Messenger RNA
100%
Non Small Cell Lung Cancer
100%
Biological Marker
25%
Chemotherapy
25%
Progression Free Survival
12%
Receptor Protein
12%
Neoplasm
12%
RNA Directed DNA Polymerase
12%
Overall Survival
12%
Biochemistry, Genetics and Molecular Biology
Insulin-Like Growth Factor 1 Receptor
100%
Messenger RNA
100%
Protein Expression
25%
Reverse Transcription Polymerase Chain Reaction
12%
Overall Survival
12%
Progression Free Survival
12%
Veterinary Science and Veterinary Medicine
Somatomedin
100%
Insulin-Like Growth Factor 1
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
14%
Neoplasm
14%